314 related articles for article (PubMed ID: 8981061)
1. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice.
De Sarro G; Chimirri A; McKernan R; Quirk K; Giusti P; De Sarro A
Pharmacol Biochem Behav; 1997 Sep; 58(1):281-9. PubMed ID: 9264104
[TBL] [Abstract][Full Text] [Related]
3. 1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice.
De Sarro G; Gitto R; Rizzo M; Zappia M; De Sarro A
Gen Pharmacol; 1996 Sep; 27(6):935-41. PubMed ID: 8909973
[TBL] [Abstract][Full Text] [Related]
4. Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines.
DeSarro GB; Zappalà M; Grasso S; Chimirri A; DeSarro A
Gen Pharmacol; 1993 Jul; 24(4):877-84. PubMed ID: 8224743
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol- 3(3H)-ones in mice.
De Sarro G; Carotti A; Campagna F; Mckernan R; Rizzo M; Falconi U; Palluotto F; Giusti P; Rettore C; De Sarro A
Pharmacol Biochem Behav; 2000 Mar; 65(3):475-87. PubMed ID: 10683488
[TBL] [Abstract][Full Text] [Related]
6. GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
de Sarro G; Chimirri A; De Sarro A; Gitto R; Grasso S; Giusti P; Chapman AG
Eur J Pharmacol; 1995 Dec; 294(2-3):411-22. PubMed ID: 8750701
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.
De Sarro G; Di Paola ED; Aguglia U; de Sarro A
Pharmacol Biochem Behav; 1996 Sep; 55(1):39-48. PubMed ID: 8870036
[TBL] [Abstract][Full Text] [Related]
9. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in thienodiazepine and benzodiazepine derivatives.
Chimirri A; Gitto R; Grasso S; Zappalà M; De Sarro A; Battista De Sarro G
Farmaco; 1994 Mar; 49(3):193-6. PubMed ID: 8043171
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant actions of fominoben: possible involvement of benzodiazepine receptors.
Baldino F; Krespan B; Geller HM
Pharmacol Biochem Behav; 1984 Jul; 21(1):137-43. PubMed ID: 6087374
[TBL] [Abstract][Full Text] [Related]
13. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine receptors studied in living primates by positron emission tomography: inverse agonist interactions.
Hantraye P; Chavoix C; Guibert B; Fukuda H; Brouillet E; Dodd RH; Prenant C; Crouzel M; Naquet R; Mazière M
Eur J Pharmacol; 1987 Jun; 138(2):239-47. PubMed ID: 3040433
[TBL] [Abstract][Full Text] [Related]
15. Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.
Zanotti A; Mariot R; Contarino A; Lipartiti M; Giusti P
Br J Pharmacol; 1996 Feb; 117(4):647-52. PubMed ID: 8646409
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional effects of beta-carbolines in reflex epilepsy.
Chapman AG; De Sarro GB; Premachandra M; Meldrum BS
Brain Res Bull; 1987 Sep; 19(3):337-46. PubMed ID: 3119161
[TBL] [Abstract][Full Text] [Related]
17. Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists.
Jensen LH; Petersen EN; Braestrup C
Life Sci; 1983 Jul; 33(4):393-9. PubMed ID: 6308372
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
19. Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABA-benzodiazepine receptor ionophore complex in cerebral cortex of rat.
Kulkarni SK; Ticku MK
Brain Res; 1990 Jun; 519(1-2):6-11. PubMed ID: 2168788
[TBL] [Abstract][Full Text] [Related]
20. The effect of benzodiazepines and beta-carbolines on GABA-stimulated chloride influx by membrane vesicles from the rat cerebral cortex.
Obata T; Yamamura HI
Biochem Biophys Res Commun; 1986 Nov; 141(1):1-6. PubMed ID: 2432889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
